Oncternal Therapeutics shares owned by Regents of the University of California
Quarter-by-quarter ownership of Oncternal Therapeutics shares owned by Regents of the University of California
from 13F filings
Historical chart of Regents of the University of California investment in Oncternal Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Oncternal Therapeutics held by Regents of the University of California consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Oncternal Therapeutics by Regents of the University of California
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $29k | 54k | 0.54 |
| 2023-09-30 | $16k | 54k | 0.30 |
| 2023-06-30 | $19k | 54k | 0.35 |
| 2023-03-31 | $42k | 54k | 0.79 |
| 2022-12-31 | $54k | 54k | 1.00 |
| 2022-09-30 | $48k | 54k | 0.90 |
| 2022-06-30 | $59k | 54k | 1.10 |
More positions owned by Regents of the University of California
View all positions for Regents of the University of California